๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for mRNA Vaccine

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms NCT06026800Phase 11 site๐Ÿ“ Hangzhou Sir Run Run Shaw Hospital ยท Tests: iNeo-Vac-R01 A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations NCT06585241Phase 46 sites๐Ÿ“ Atlanta๐Ÿ“ Decatur๐Ÿ“ Baton Rouge ModernaTX, Inc. ยท Tests: mRNA-1273 Variant-containing Formulation Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors NCT07583654Phase 11 site๐Ÿ“ Chengdu West China Hospital ยท Tests: CP-IL22BP mRNA intratumorally injection A Study to Learn About mRNA Vaccines Against Influenza in Adults NCT07431853Phase 215 sites๐Ÿ“ Mobile๐Ÿ“ Walnut Creek๐Ÿ“ Milford Pfizer ยท Tests: Vaccine Candidate #1, Vaccine Candidate #2, Vaccine Candidate #3, Vaccine Candidate #4, Vaccine Candidate #5 Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) NCT06141369NA1 site๐Ÿ“ Shanghai Shanghai Jiao Tong University School of Medicine ยท Tests: individualized mRNA neoantigen vaccine (mRNA-0523-L001) A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age NCT07851246Phase 312 sites๐Ÿ“ Glendale๐Ÿ“ Tucson๐Ÿ“ San Diego GlaxoSmithKline ยท Tests: mRNA Seasonal Flu vaccine, Comparator 1, Comparator 2 Phase III Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above NCT07817108Phase 34 sites๐Ÿ“ Jinan๐Ÿ“ Nanning๐Ÿ“ Shijiazhuang Suzhou Abogen Biosciences Co., Ltd. ยท Tests: ABO1108, Placebo mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults NCT07557602Phase 12 sites๐Ÿ“ Herston๐Ÿ“ Melbourne Vaccine Company, Inc, a wholly owned subsidiary of Eli Lillโ€ฆ ยท Tests: VXCO-102, Placebo Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults NCT07757802Phase 18 sites๐Ÿ“ San Francisco๐Ÿ“ Atlanta๐Ÿ“ Boston National Institute of Allergy and Infectious Diseases (NIAIโ€ฆ ยท Tests: DV901-NP, DV902-NP, CH505 TF mRNA-gp160, CH505 w24 mRNA-gp160, ACU-026-001-1 A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age NCT07730450Phase 45 sites๐Ÿ“ Walnut Creek๐Ÿ“ Miami Lakes๐Ÿ“ Honolulu BioNTech SE ยท Tests: BNT162b2 Vaccine, Tdap Vaccine A Study on the Efficacy of a Vaccine Against Influenza in Adults โ‰ฅ65 Years of Age NCT07805707Phase 3163 sites๐Ÿ“ Anniston๐Ÿ“ Guntersville๐Ÿ“ Glendale GlaxoSmithKline ยท Tests: mRNA Seasonal Flu vaccine, Licensed Influenza Vaccine Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer NCT06326736EARLY Phase 11 site๐Ÿ“ Nanjing Jinling Hospital, China ยท Tests: Surgery, Camrelizumab, SJ-Neo006, Gemcitabine+Abraxane An Experimental Medicine Multicenter Trial to Evaluate the Safety and Immunogenicity of Experimental Versus Authorized SARS-CoV-2 Vaccine Candidates as a Booster Dose in Healthy Participants Previously Vaccinated With Authorized mRNA SARS-CoV-2 Vaccines. NCT07605520EARLY Phase 13 sites๐Ÿ“ Crรฉteil๐Ÿ“ Paris๐Ÿ“ Lausanne ANRS, Emerging Infectious Diseases ยท Tests: CD40.RBDv vaccine adjuvanted with Hiltonolยฎ, CD40.Pan.CoV vaccine adjuvanted with Hiltonolยฎ, Comirnatyยฎ vaccine, Nuvaxoโ€ฆ XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer NCT06353646NA1 site๐Ÿ“ Beijing Wu Wenming ยท Tests: XH001, Ipilimumab Injection, Sintilimab injection, Chemotherapy Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine NCT07400003Phase 1, Phase 21 site๐Ÿ“ Xinjiang Sinovac Biotech Co., Ltd ยท Tests: Low-dose experimental vaccine, High-dose experimental vaccine, Active-controlled vaccine A, Active-controlled vaccine Bโ€ฆ A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVIV Vaccine in Patients With Ovarian Cancer After Surgery NCT07676890Phase 11 site๐Ÿ“ Chengdu West China Hospital ยท Tests: Low Dose NeoOVIV, Medium dose NeoOVIV, High dose NeoOVIV Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne NCT07013747Phase 1, Phase 24 sites๐Ÿ“ Encino๐Ÿ“ Brandon๐Ÿ“ Jacksonville Sanofi Pasteur, a Sanofi Company ยท Tests: Acne mRNA vaccine, Placebo mRNA Vaccine for Advanced Lung Cancer and Pulmonary Metastases of Solid Tumors NCT06928922EARLY Phase 11 site๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: BMD006 monotherapy, BMD006 in combination with Immuno-Oncology (IO) therapy (Dose Escalation), BMD006 in combination wiโ€ฆ Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma NCT07077356Phase 11 site๐Ÿ“ Chengdu West China Hospital ยท Tests: HBV mRNA vaccine Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms NCT06026774Phase 11 site๐Ÿ“ Hangzhou Sir Run Run Shaw Hospital ยท Tests: iNeo-Vac-R01 in combination with standard adjuvant therapy A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection NCT07051187Phase 11 site๐Ÿ“ Chengdu Jiyan Liu ยท Tests: WGc0201 Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer NCT06496373EARLY Phase 11 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: Fixed neoantigen tumor vaccine, personalized neoantigen tumor vaccine, PD-1 inhibitor Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma NCT06932861EARLY Phase 11 site๐Ÿ“ Beijing Xinxin Zhang ยท Tests: personalized neoantigen mRNA vaccine Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults NCT06821126Phase 1, Phase 25 sites๐Ÿ“ Dijon๐Ÿ“ Lyon๐Ÿ“ Paris ANRS, Emerging Infectious Diseases ยท Tests: LVT-001, Cormirnaty Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors NCT06195384Phase 11 site๐Ÿ“ Guangzhou Second Affiliated Hospital of Guangzhou Medical University ยท Tests: Neoantigen mRNA Vaccine Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies NCT07004244Phase 11 site๐Ÿ“ Chengdu Sichuan University ยท Tests: KRAS-mutated mRNA vaccine, TORIPALIMAB, Pemetrexed+carboplatin Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne NCT06316297Phase 1, Phase 294 sites๐Ÿ“ Scottsdale๐Ÿ“ Cerritos๐Ÿ“ Encino Sanofi Pasteur, a Sanofi Company ยท Tests: Acne mRNA vaccine, Placebo A Clinical Trial Evaluating IL-22BP/LNP Compound in Refractory Malignant Solid Tumors for Safety, Tolerability and Activity NCT07100210Phase 11 site๐Ÿ“ Chengdu Xingchen Peng ยท Tests: IL-22BP mRNA vaccine injection A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa NCT07379580Phase 26 sites๐Ÿ“ Kinshasa๐Ÿ“ Kinshasa๐Ÿ“ Cape Town BioNTech SE ยท Tests: BNT166a, Placebo Safety and Tolerability of AI-Designed Pan-Cancer Neoantigen mRNA Vaccine (PAN-NeoVax) in Advanced Solid Tumors NCT07560943Phase 12 sites๐Ÿ“ Chengdu๐Ÿ“ Chengdu West China Hospital ยท Tests: PAN-NeoVax (25 ฮผg), PAN-NeoVax (50 ฮผg), PAN-NeoVax (100 ฮผg)
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy